SUNBIRD BIO

With a leading and highly motivated team of scientists and researchers, Sunbird Bio has proven the capabilities of the platform through a publication in Nature Communications that demonstrated strong correlation of beta amyloid, associated with Alzheimer's disease, with the gold standard, Amyloid PET (Positron Emission Tomography). Sunbird Bio is rapidly moving towards introducing the technology to the market... SunBird Bio is a Singapore biotechnology start-up, exploring new frontiers in molecular diagnostics. We aim to provide clinicians and researchers with blood-based diagnostics that are equivalent to the gold standard and enable breakthrough treatment of neurodegenerative diseases... In order to make this vision a reality, we have developed the proprietary APEX platform that detects protein aggregates via extracellular vesicles that pass through the blood-brain barrier.

Primary location: Singapore